Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Duration of adjuvant treatment: Is “as long as possible” the key?

PRO: As long as possible

Date

27 Mar 2025

Session

Duration of adjuvant treatment: Is “as long as possible” the key?

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Hye Ryun Kim

Authors

H.R. Kim

Author affiliations

Yonsei Cancer Center Yonsei University, Seoul/KR

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

27 Mar 2025

Introduction and first vote

Presenter: Heather Wakelee

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast

27 Mar 2025

CONTRA: Limited duration

Presenter: Rafal Dziadziuszko

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast

27 Mar 2025

Second vote and conclusions/discussion

Presenter: Heather Wakelee

Session: Duration of adjuvant treatment: Is “as long as possible” the key?

Resources:

Slides

Webcast